Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoxia-Ischemia, Brain | 14 | 2026 | 59 | 4.630 |
Why?
|
| White Matter | 9 | 2026 | 100 | 3.570 |
Why?
|
| Cerebral Palsy | 13 | 2026 | 100 | 3.240 |
Why?
|
| Diffusion Tensor Imaging | 7 | 2026 | 78 | 1.960 |
Why?
|
| Brain | 18 | 2025 | 2439 | 1.830 |
Why?
|
| Animals, Newborn | 15 | 2026 | 526 | 1.830 |
Why?
|
| Rabbits | 21 | 2025 | 582 | 1.680 |
Why?
|
| Muscle Hypertonia | 6 | 2017 | 16 | 1.630 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2026 | 3612 | 1.620 |
Why?
|
| Interneurons | 2 | 2025 | 103 | 1.540 |
Why?
|
| Fetal Hypoxia | 4 | 2017 | 14 | 1.350 |
Why?
|
| Hypoxia | 5 | 2025 | 682 | 1.270 |
Why?
|
| Brain Injuries | 4 | 2024 | 143 | 1.260 |
Why?
|
| Long-Term Potentiation | 2 | 2020 | 51 | 1.190 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2023 | 304 | 1.030 |
Why?
|
| Pyramidal Tracts | 1 | 2026 | 16 | 0.950 |
Why?
|
| Disease Models, Animal | 13 | 2026 | 2577 | 0.940 |
Why?
|
| Infant, Premature | 4 | 2026 | 307 | 0.940 |
Why?
|
| Protons | 2 | 2023 | 102 | 0.930 |
Why?
|
| Glutamic Acid | 1 | 2026 | 136 | 0.900 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2026 | 46 | 0.900 |
Why?
|
| Synaptic Transmission | 1 | 2026 | 229 | 0.840 |
Why?
|
| Cerebral Cortex | 2 | 2025 | 573 | 0.830 |
Why?
|
| Movement Disorders | 3 | 2014 | 45 | 0.830 |
Why?
|
| Animals | 32 | 2026 | 28981 | 0.810 |
Why?
|
| Pregnancy | 17 | 2024 | 3269 | 0.780 |
Why?
|
| Hypoxia, Brain | 3 | 2020 | 41 | 0.760 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 217 | 0.750 |
Why?
|
| Isoflurane | 1 | 2023 | 57 | 0.730 |
Why?
|
| Oxygen | 3 | 2023 | 773 | 0.690 |
Why?
|
| Neuronal Plasticity | 2 | 2020 | 200 | 0.680 |
Why?
|
| Nerve Net | 1 | 2025 | 404 | 0.650 |
Why?
|
| Sensation | 1 | 2020 | 49 | 0.600 |
Why?
|
| Mice, Inbred C57BL | 6 | 2026 | 3616 | 0.590 |
Why?
|
| Serotonin | 2 | 2023 | 211 | 0.580 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 661 | 0.580 |
Why?
|
| Motor Activity | 2 | 2015 | 328 | 0.570 |
Why?
|
| Memory Disorders | 1 | 2019 | 73 | 0.560 |
Why?
|
| Ischemia | 2 | 2024 | 263 | 0.560 |
Why?
|
| Anesthesia | 1 | 2020 | 176 | 0.530 |
Why?
|
| Child Development | 1 | 2020 | 179 | 0.530 |
Why?
|
| Central Nervous System | 2 | 2017 | 144 | 0.510 |
Why?
|
| Mice | 8 | 2026 | 12735 | 0.500 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2014 | 33 | 0.480 |
Why?
|
| Learning | 1 | 2020 | 311 | 0.480 |
Why?
|
| Nitric Oxide Synthase Type I | 3 | 2012 | 22 | 0.470 |
Why?
|
| Female | 25 | 2026 | 51761 | 0.450 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 120 | 0.450 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 1 | 2015 | 14 | 0.440 |
Why?
|
| Paracrine Communication | 1 | 2015 | 32 | 0.440 |
Why?
|
| Infant, Newborn | 7 | 2026 | 2551 | 0.430 |
Why?
|
| Spinal Cord | 2 | 2023 | 243 | 0.430 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 311 | 0.430 |
Why?
|
| Picrotoxin | 2 | 2025 | 7 | 0.420 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2014 | 3 | 0.420 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2015 | 91 | 0.410 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2026 | 87 | 0.390 |
Why?
|
| Uterus | 1 | 2015 | 231 | 0.390 |
Why?
|
| Placenta | 1 | 2015 | 202 | 0.390 |
Why?
|
| Electric Stimulation | 3 | 2020 | 341 | 0.390 |
Why?
|
| Anisotropy | 3 | 2023 | 61 | 0.370 |
Why?
|
| Muscle, Skeletal | 3 | 2014 | 523 | 0.370 |
Why?
|
| Nitric Oxide | 3 | 2012 | 286 | 0.360 |
Why?
|
| Olfactory Perception | 1 | 2012 | 25 | 0.360 |
Why?
|
| Muscle Hypotonia | 1 | 2012 | 47 | 0.360 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 643 | 0.350 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2023 | 1304 | 0.340 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 148 | 0.330 |
Why?
|
| Infant | 5 | 2026 | 3361 | 0.320 |
Why?
|
| Aging | 2 | 2006 | 770 | 0.320 |
Why?
|
| Contrast Media | 1 | 2015 | 1013 | 0.310 |
Why?
|
| Rats | 3 | 2025 | 4074 | 0.270 |
Why?
|
| Oligodendroglia | 2 | 2023 | 78 | 0.260 |
Why?
|
| Brain Mapping | 2 | 2012 | 570 | 0.260 |
Why?
|
| Action Potentials | 2 | 2014 | 611 | 0.250 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2007 | 19 | 0.250 |
Why?
|
| Motor Skills Disorders | 1 | 2007 | 14 | 0.250 |
Why?
|
| Neurons | 3 | 2025 | 1626 | 0.250 |
Why?
|
| Fetus | 4 | 2012 | 238 | 0.240 |
Why?
|
| Sensation Disorders | 1 | 2006 | 33 | 0.240 |
Why?
|
| Neurovascular Coupling | 1 | 2025 | 6 | 0.230 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2025 | 7 | 0.230 |
Why?
|
| Smell | 1 | 2006 | 123 | 0.220 |
Why?
|
| Male | 9 | 2026 | 47263 | 0.220 |
Why?
|
| Multimodal Imaging | 1 | 2026 | 115 | 0.220 |
Why?
|
| Corpus Callosum | 1 | 2005 | 58 | 0.220 |
Why?
|
| Hypothermia, Induced | 1 | 2025 | 94 | 0.210 |
Why?
|
| Microbiota | 2 | 2022 | 472 | 0.210 |
Why?
|
| Behavior, Animal | 2 | 2018 | 399 | 0.200 |
Why?
|
| Rats, Wistar | 1 | 2024 | 304 | 0.200 |
Why?
|
| Time Factors | 4 | 2017 | 5577 | 0.200 |
Why?
|
| Neurites | 1 | 2023 | 38 | 0.190 |
Why?
|
| Macromolecular Substances | 1 | 2023 | 162 | 0.190 |
Why?
|
| Motor Cortex | 1 | 2025 | 210 | 0.190 |
Why?
|
| Maze Learning | 2 | 2019 | 33 | 0.180 |
Why?
|
| Emotions | 1 | 2006 | 387 | 0.180 |
Why?
|
| Antioxidants | 2 | 2015 | 236 | 0.180 |
Why?
|
| Visual Perception | 1 | 2006 | 341 | 0.180 |
Why?
|
| Memory, Short-Term | 1 | 2006 | 258 | 0.180 |
Why?
|
| Gestational Age | 2 | 2012 | 342 | 0.170 |
Why?
|
| Escherichia coli | 1 | 2024 | 572 | 0.170 |
Why?
|
| N-Methylaspartate | 1 | 2020 | 45 | 0.160 |
Why?
|
| Cognition | 1 | 2006 | 669 | 0.160 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2020 | 27 | 0.160 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2020 | 119 | 0.160 |
Why?
|
| Predictive Value of Tests | 3 | 2012 | 1785 | 0.150 |
Why?
|
| Hippocampus | 2 | 2025 | 465 | 0.150 |
Why?
|
| Calcium Signaling | 1 | 2020 | 143 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 1 | 2020 | 382 | 0.150 |
Why?
|
| Cell Death | 1 | 2020 | 258 | 0.150 |
Why?
|
| Olfactory Bulb | 2 | 2012 | 41 | 0.150 |
Why?
|
| Organ Size | 2 | 2018 | 370 | 0.150 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 48 | 0.140 |
Why?
|
| Hemodynamics | 1 | 2023 | 746 | 0.140 |
Why?
|
| Caspase 3 | 1 | 2019 | 161 | 0.140 |
Why?
|
| Humans | 13 | 2026 | 98370 | 0.140 |
Why?
|
| Age Factors | 2 | 2014 | 1974 | 0.140 |
Why?
|
| Child, Preschool | 1 | 2026 | 4042 | 0.140 |
Why?
|
| Fear | 1 | 2019 | 91 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 880 | 0.140 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 239 | 0.130 |
Why?
|
| Models, Animal | 2 | 2012 | 282 | 0.130 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 182 | 0.130 |
Why?
|
| Macaca mulatta | 1 | 2020 | 466 | 0.130 |
Why?
|
| Fluoresceins | 1 | 2017 | 43 | 0.130 |
Why?
|
| Gliosis | 1 | 2017 | 32 | 0.130 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2017 | 56 | 0.130 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2017 | 122 | 0.130 |
Why?
|
| Movement | 2 | 2016 | 313 | 0.120 |
Why?
|
| Infant, Extremely Premature | 1 | 2016 | 45 | 0.120 |
Why?
|
| Heart Rate | 1 | 2019 | 534 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 66 | 0.110 |
Why?
|
| Neural Pathways | 1 | 2017 | 334 | 0.110 |
Why?
|
| Calibration | 1 | 2015 | 109 | 0.110 |
Why?
|
| Microspheres | 1 | 2015 | 97 | 0.110 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2015 | 50 | 0.110 |
Why?
|
| Neural Conduction | 1 | 2014 | 72 | 0.100 |
Why?
|
| Electron Microscope Tomography | 1 | 2014 | 25 | 0.100 |
Why?
|
| Leukoencephalopathies | 1 | 2014 | 14 | 0.100 |
Why?
|
| Gadolinium DTPA | 1 | 2015 | 239 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 137 | 0.100 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 257 | 0.100 |
Why?
|
| Perfusion | 1 | 2015 | 271 | 0.100 |
Why?
|
| Evoked Potentials | 1 | 2014 | 191 | 0.090 |
Why?
|
| Muscle Tonus | 1 | 2012 | 16 | 0.090 |
Why?
|
| Placental Insufficiency | 1 | 2012 | 4 | 0.090 |
Why?
|
| Olfactory Mucosa | 1 | 2012 | 33 | 0.090 |
Why?
|
| Valinomycin | 1 | 2012 | 8 | 0.090 |
Why?
|
| Ionophores | 1 | 2012 | 14 | 0.090 |
Why?
|
| Carbocyanines | 1 | 2012 | 18 | 0.090 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2012 | 19 | 0.090 |
Why?
|
| O Antigens | 1 | 2012 | 12 | 0.090 |
Why?
|
| Metalloporphyrins | 1 | 2012 | 26 | 0.090 |
Why?
|
| Chromans | 1 | 2012 | 28 | 0.090 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2012 | 34 | 0.090 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 493 | 0.090 |
Why?
|
| Ascorbic Acid | 1 | 2012 | 41 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1945 | 0.090 |
Why?
|
| Superoxides | 1 | 2012 | 76 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 1817 | 0.090 |
Why?
|
| Microvessels | 1 | 2012 | 70 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 220 | 0.090 |
Why?
|
| Abortion, Spontaneous | 1 | 2012 | 74 | 0.090 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 179 | 0.090 |
Why?
|
| Benzimidazoles | 1 | 2012 | 118 | 0.080 |
Why?
|
| Mitochondria | 2 | 2012 | 650 | 0.080 |
Why?
|
| Myelin Sheath | 2 | 2023 | 69 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2012 | 186 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 2897 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2012 | 722 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2792 | 0.080 |
Why?
|
| Electroencephalography | 1 | 2014 | 799 | 0.070 |
Why?
|
| Gene Expression | 1 | 2012 | 1322 | 0.070 |
Why?
|
| Child | 1 | 2020 | 7750 | 0.070 |
Why?
|
| Biomarkers | 1 | 2015 | 2021 | 0.070 |
Why?
|
| Stimulation, Chemical | 1 | 2006 | 54 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2006 | 19 | 0.060 |
Why?
|
| Manganese | 1 | 2006 | 58 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2006 | 66 | 0.060 |
Why?
|
| Odorants | 1 | 2006 | 73 | 0.060 |
Why?
|
| Epithelium | 1 | 2006 | 316 | 0.060 |
Why?
|
| Axons | 1 | 2006 | 181 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2007 | 890 | 0.060 |
Why?
|
| ROC Curve | 1 | 2007 | 793 | 0.050 |
Why?
|
| Language | 1 | 2006 | 165 | 0.050 |
Why?
|
| Fetal Development | 1 | 2024 | 37 | 0.050 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2023 | 14 | 0.050 |
Why?
|
| Cations | 1 | 2023 | 29 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2006 | 1145 | 0.050 |
Why?
|
| Glucose | 1 | 2025 | 704 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 1296 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2023 | 193 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2025 | 1752 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2005 | 416 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2012 | 3633 | 0.040 |
Why?
|
| Risk Factors | 1 | 2012 | 6273 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 85 | 0.030 |
Why?
|
| Spatial Memory | 1 | 2018 | 30 | 0.030 |
Why?
|
| Cell Count | 1 | 2018 | 195 | 0.030 |
Why?
|
| Gray Matter | 1 | 2018 | 48 | 0.030 |
Why?
|
| Bacteria | 1 | 2022 | 546 | 0.030 |
Why?
|
| Social Behavior | 1 | 2018 | 316 | 0.030 |
Why?
|
| United States | 1 | 2006 | 8262 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 92 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 578 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2012 | 284 | 0.020 |
Why?
|
| Joints | 1 | 2009 | 34 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2009 | 72 | 0.020 |
Why?
|
| Postural Balance | 1 | 2009 | 55 | 0.020 |
Why?
|
| Swimming | 1 | 2009 | 65 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2009 | 178 | 0.020 |
Why?
|
| Extremities | 1 | 2009 | 173 | 0.020 |
Why?
|
| Aged | 1 | 2006 | 21844 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4818 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2009 | 517 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 642 | 0.010 |
Why?
|
| Abruptio Placentae | 1 | 2005 | 13 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2009 | 411 | 0.010 |
Why?
|
| Adult | 1 | 2006 | 29587 | 0.010 |
Why?
|
| Middle Aged | 1 | 2006 | 29532 | 0.010 |
Why?
|